Magstim acquires Electrical Geodesics, Inc. (EGI) product portfolio

Magstim, the global leader in Transcranial Magnetic Stimulation (TMS), today announced an agreement to acquire the product portfolio of Electrical Geodesics, Inc. (EGI) from Royal Philips, a global leader in health technology. EGI designs non-invasive multimodal technologies to monitor brain activity and deliver transcranial electrical stimulation in brain research. Magstim will acquire EGI hardware, software and sensor nets assets and will immediately manage global sales, service and support. Philips will support the transition through the end of 2020.

Magstim Acquires Electrical Geodesics, Inc. (EGI) product portfolio
Study of Brain

This adds high-density EEG to our product portfolio supporting more than 1,200 research labs and clinics that focus on mental health, brain disorders and cognitive neuroscience. Magstim has been pioneering and advancing transcranial magnetic stimulation for 30 years. High-density EEG closes the loop for the development of a comprehensive system for non-invasive neuromodulation. Magstim and EGI share a legacy and passion for innovation in neuroscience.”

Lothar Krinke, Group CEO, Magstim

Electroencephalography (EEG) is used to evaluate the electrical activity in the brain. EGI’s proprietary dense array EEG technology gathers data from more electrodes than conventional EEG. EGI’s Geodesic Sensor Net (GSN) is used globally by neuroscience researchers because of its ease of use, comfort and ability to produce high-resolution data.

Merging TMS and EEG facilitates future innovations leading to personalized treatments based on biological markers. I am confident this will lead to better patient outcomes.”

Dr. Alvaro Pascual-Leone, MD, PhD, Professor of Neurology, Harvard Medical School

Magstim will continue a presence in EGI’s Oregon office supported by Magstim’s global offices in the UK, Netherlands and Minneapolis. Magstim is backed by Telegraph Hill Partners, a San Francisco based private equity company. Magstim is also member of Medical Alley, the world’s leading health technology innovation cluster and home to the nation’s largest private health insurer and more than 1,000 healthcare companies, employing millions worldwide. Magstim’s sister brands include Neurosign and Technomed.

MAGSTIM is the pioneer of Transcranial Magnetic Stimulation. TMS is a research tool and an effective, non-invasive, outpatient therapy that is cleared by the FDA for major depressive disorder. For more information about this integration, visit www.MagstimEGI.com

For more information about Electrical Geodesics, visit www.egi.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Magstim Inc.. (2020, July 06). Magstim acquires Electrical Geodesics, Inc. (EGI) product portfolio. News-Medical. Retrieved on August 08, 2020 from https://www.news-medical.net/news/20200706/Magstim-acquires-Electrical-Geodesics-Inc-(EGI)-product-portfolio.aspx.

  • MLA

    Magstim Inc.. "Magstim acquires Electrical Geodesics, Inc. (EGI) product portfolio". News-Medical. 08 August 2020. <https://www.news-medical.net/news/20200706/Magstim-acquires-Electrical-Geodesics-Inc-(EGI)-product-portfolio.aspx>.

  • Chicago

    Magstim Inc.. "Magstim acquires Electrical Geodesics, Inc. (EGI) product portfolio". News-Medical. https://www.news-medical.net/news/20200706/Magstim-acquires-Electrical-Geodesics-Inc-(EGI)-product-portfolio.aspx. (accessed August 08, 2020).

  • Harvard

    Magstim Inc.. 2020. Magstim acquires Electrical Geodesics, Inc. (EGI) product portfolio. News-Medical, viewed 08 August 2020, https://www.news-medical.net/news/20200706/Magstim-acquires-Electrical-Geodesics-Inc-(EGI)-product-portfolio.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.